Literature DB >> 21131737

[Direct interaction between BAG5 protein and Parkin protein].

Xuejing Wang1, Jifeng Guo, Hong Jiang, Lu Shen, Beisha Tang.   

Abstract

OBJECTIVE: To explore the interaction between BCL2-associated athanogene 5 (BAG5) and Parkin protein,and the regulatory mechanism of BAG5 protein on the level of Parkin protein.
METHODS: We performed GST pull-down assay to identify which domain of PINK1 interacted with Parkin, and generated different deletions of BAG5 to identify the domains. Chase time experiment was done to determine the effect of co-regulation of BAG5 protein on the ubiquitination. We further examined the possible interaction between Parkin and PINK1 in 293A cells by co-immunoprecipitation method.
RESULTS: BAG5 directly interacted with the Parkin, and all the 4 BAG domains interacted with the Parkin. BAG5 stabilized the Parkin by interfering its degradation via the ubiquitin-mediated proteasomal pathway.
CONCLUSION: BAG5 directly interacts with the Parkin, and BAG5 stabilizes the Parkin via the ubiquitin-mediated proteasomal pathway.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21131737     DOI: 10.3969/j.issn.1672-7347.2010.11.007

Source DB:  PubMed          Journal:  Zhong Nan Da Xue Xue Bao Yi Xue Ban        ISSN: 1672-7347


  3 in total

1.  Bag5 protects neuronal cells from amyloid β-induced cell death.

Authors:  Ke Guo; Liuhong Li; Gang Yin; Xiaohong Zi; Lei Liu
Journal:  J Mol Neurosci       Date:  2014-11-01       Impact factor: 3.444

2.  Bcl-2 associated athanogene 5 (Bag5) is overexpressed in prostate cancer and inhibits ER-stress induced apoptosis.

Authors:  Anja Bruchmann; Corinna Roller; Tamara Vanessa Walther; Georg Schäfer; Sara Lehmusvaara; Tapio Visakorpi; Helmut Klocker; Andrew C B Cato; Danilo Maddalo
Journal:  BMC Cancer       Date:  2013-03-01       Impact factor: 4.430

Review 3.  RBR E3 ubiquitin ligases: new structures, new insights, new questions.

Authors:  Donald E Spratt; Helen Walden; Gary S Shaw
Journal:  Biochem J       Date:  2014-03-15       Impact factor: 3.857

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.